electroCore to Present at Noble Capital Markets’ Fifteenth Annual Investor Conference

    NEXT STORY
    BIOLIFE4D Appoints Management Advisory Board
    PREV STORY
    Conatus Pharmaceuticals Announces Publications Expanding on Previously Reported Results from Completed Phase 2 NAFLD-NASH, Portal Hypertension and Liver Cirrhosis Clinical Trials
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    MapKure, BeiGene and SpringWorks Announce Initiation of Phase 1 Clinical Trial of BGB-3245, a Selective Next-Generation B-RAF Inhibitor, in Adult Patients with Advanced or Refractory Solid Tumors

    author_avatar
    NASDAQ Market News

    Botulinum Toxin Market revenue to cross USD 8.9 Bn by 2026: Global Market Insights, Inc.

    author_avatar
    NASDAQ Market News

    North American Partners in Anesthesia provides critical services to AdvantageCare Physicians patients in East New York, Brooklyn

    author_avatar
    NASDAQ Market News